For decades, taking a daily low-dose aspirin was a widely accepted practice for preventing heart attacks and strokes. But a series of clinical trials have led to a major shift in medical guidance — ...
The global aspirin drug market is poised for substantial growth over the next decade, with its value expected to increase ...
Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.
SurvivorNet on MSN3d
Over-The-Counter Aspirin and its ‘Practice-Changing’ Impact on Colorectal Cancer — Results from a Remarkable Study that Could Positively Affect ‘More Than a Third of ...A randomized study has produced some hopeful news for colorectal cancer survivors with an unlikely suspect: the commonly used ...
Updates in new antiplatelet therapies, new patient populations for PCI and AI to guide CAD staging were among the top ...
Advancements in non-opioid therapies, AI-integrated solutions, and regenerative medicine drive transformative growth in the pain management market. AUSTIN, TX, UNITED STATES, January 21, 2025 ...
Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...
aDivision of Hematology and Hematological Malignancies, Department of Medicine, University of Calgary, Calgary, AB, Canada bDepartment of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine ...
Bayer AG was told by a jury to pay $100 million to four people at a Seattle-area school who said their exposure at the facility to toxic chemicals made by the company’s Monsanto unit caused brain ...
Bayer’s Parkinson’s disease cell therapy is moving into late-stage testing, with the upcoming trial set to be the first registrational phase 3 study for an investigational allogeneic cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback